170 related articles for article (PubMed ID: 15150095)
1. Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment.
El-Hashemite N; Zhang H; Walker V; Hoffmeister KM; Kwiatkowski DJ
Cancer Res; 2004 May; 64(10):3436-43. PubMed ID: 15150095
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.
El-Hashemite N; Kwiatkowski DJ
Am J Respir Cell Mol Biol; 2005 Sep; 33(3):227-30. PubMed ID: 15994429
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
4. Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
Lee L; Sudentas P; Dabora SL
Genes Chromosomes Cancer; 2006 Oct; 45(10):933-44. PubMed ID: 16845661
[TBL] [Abstract][Full Text] [Related]
5. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
Chang YJ; Holtzman MJ; Chen CC
Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation.
Choi WH; Ji KA; Jeon SB; Yang MS; Kim H; Min KJ; Shong M; Jou I; Joe EH
Biochem Biophys Res Commun; 2005 Apr; 329(1):125-31. PubMed ID: 15721283
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
Imai K; Kurita-Ochiai T; Ochiai K
FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.
Goncharova EA; Goncharov DA; Damera G; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
Mol Pharmacol; 2009 Oct; 76(4):766-77. PubMed ID: 19596836
[TBL] [Abstract][Full Text] [Related]
9. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
10. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.
Messina MP; Rauktys A; Lee L; Dabora SL
BMC Pharmacol; 2007 Nov; 7():14. PubMed ID: 17986349
[TBL] [Abstract][Full Text] [Related]
12. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2.
Sakamoto E; Hato F; Kato T; Sakamoto C; Akahori M; Hino M; Kitagawa S
J Leukoc Biol; 2005 Jul; 78(1):301-9. PubMed ID: 15845643
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
Nandan D; Reiner NE
J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
Hussain S; Zwilling BS; Lafuse WP
J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
[TBL] [Abstract][Full Text] [Related]
17. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
[TBL] [Abstract][Full Text] [Related]
19. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.
El-Hashemite N; Walker V; Zhang H; Kwiatkowski DJ
Cancer Res; 2003 Sep; 63(17):5173-7. PubMed ID: 14500340
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
Lee N; Woodrum CL; Nobil AM; Rauktys AE; Messina MP; Dabora SL
BMC Pharmacol; 2009 Apr; 9():8. PubMed ID: 19368729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
